Membrane-Bound Complement Regulatory Proteins in Breast Cancer: Are They Best Therapeutic Targets?
Breast cancer is one of the most aggressive diseases in women, responsible for thousands of deaths annually and millions of new diagnoses; its treatment presents multiple obstacles due to late diagnosis and the various mechanisms of tumor resistance. In breast cancer the membrane-bound complement re...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2023
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/86257 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Membrane-Bound Complement Regulatory Proteins in Breast Cancer: Are They Best Therapeutic Targets?
- Cell Cycle Regulatory Proteins in Breast Cancer: Molecular Determinants of Drug Resistance and Targets for Anticancer Therapies
- Therapeutic Targeting of Osteopontin in Breast Cancer Cells
- Prostate Specific Membrane Antigen as Biomarker and Therapeutic Target for Prostate Cancer
- Preclinical and Clinical Developments in Molecular Targeting Therapeutic Strategies for Breast Cancer
- Approaches to Analyze Protein-Protein Interactions of Membrane Proteins
- Neuropilin-1: A Promising Therapeutic Target for Triple-Negative Breast Cancer